Evidence-Based Prioritization and Scoring of Genomic Loci Interacting with Pioglitazone Therapeutic Response in Diabetic Patients. Precision Medicine Communications, [S. l.], v. 2, n. 2, p. 91–108, 2022. DOI: 10.55627/pmc.002.02.0188. Disponível em: https://rootspress.org/journals/PMC/article/view/188. Acesso em: 3 apr. 2026.